Malikireddy Sravanthi
Ophthalmology, Modern Eye Hospital, Chittoor, IND.
Cureus. 2024 Jan 29;16(1):e53204. doi: 10.7759/cureus.53204. eCollection 2024 Jan.
Xeroderma pigmentosum (XP) is a rare, autosomal recessive disorder characterized by defective DNA repair. Patients with this disorder are at increased risk of developing various oculocutaneous malignancies. We report a rare case of a child with XP with bilateral ocular surface squamous neoplasia (OSSN) and left eye (OS) medial canthal basal cell carcinoma (BCC). Ultrasound biomicroscopy and contrast-enhanced computed tomography (CECT) of the orbit showed intraocular extension with no orbital involvement. The patient was started on topical interferon therapy in both eyes for OSSN. Topical 5% imiquimod was started for BCC for eight hours a day and then washed off. During follow-up, there was no recurrence of tumors. Since ocular and cutaneous neoplasms tend to occur at an early age in XP with a high rate of recurrence and they tend to be more aggressive, multimodal therapy with long-term follow-up is more advantageous for these patients. Topical 5% imiquimod can be used as a treatment for periocular BCC as an alternative to excision.
着色性干皮病(XP)是一种罕见的常染色体隐性疾病,其特征为DNA修复缺陷。患有这种疾病的患者患各种眼皮肤恶性肿瘤的风险增加。我们报告了一例罕见的患有XP的儿童病例,该患儿患有双侧眼表鳞状细胞瘤(OSSN)和左眼(OS)内眦基底细胞癌(BCC)。眼眶的超声生物显微镜检查和增强计算机断层扫描(CECT)显示肿瘤向眼内扩展,但未累及眼眶。该患者开始接受双眼局部干扰素治疗OSSN。开始对BCC局部使用5%咪喹莫特,每天使用8小时,然后洗掉。在随访期间,肿瘤未复发。由于眼和皮肤肿瘤在XP患者中往往在早年发生,复发率高,且往往更具侵袭性,因此对这些患者进行长期随访的多模式治疗更为有利。局部使用5%咪喹莫特可作为眼周BCC切除的替代治疗方法。